Neonatology Faculty
Program Leadership
Thomas Diacovo, MD Medical School: McGill University Interests:
|
||
Jennifer Pynn, MD Medical School: Downstate Medical Center Interests: Medical Education, Non-Invasive Ventilation Strategies, Chronic Lung Disease Prevention |
||
Shanthy Sridhar, MD, FAAP Medical School: Coimbatore Medical College Interests: Neonatal Transport, Newborn Resuscitation, Antibiotic Stewardship |
||
Core Faculty |
||
Surabhi Aggarwal, MD Medical School: Lady Hardinge Medical College, New Delhi, India Interests: Neonatal Nutrition, Medical Education, Simulation |
||
Carly Gomes, MD Medical School: Stanford School of Medicine Interests: Neonatal Pain, Brain Development |
||
Interim NICU Medical Director Professor of Clinical Pediatrics Medical School: Universita Karlova |
||
Echezona Maduekwe, MD Interests: General Newborn Care, Prematurity, Reduction of Morbidity and Mortality Related to Hypoxic Injury in Newborns
|
||
Hormuz Nicolwala, MD Interests: Patient Safety, Point of Care Ultrasound, Improving Neonatal Care with Technology |
||
Aruna Parekh, MD Medical School: Bombay University, India Interests: High Risk Follow-Up of NICU Graduates, Developmental Interventions, IVH Prevention Strategies, Simulation/Procedures, Professionalism in the Workplace |
||
Margaret Pearce, MD Pediatric Residency: Richmond University Medical Center Interests: Neonatal Nutrition, Quality Improvement, High Risk Follow-up of NICU Graduates |
||
Esther Speer, MD Medical School: Johannes Gutenberg University Mainz, Germany
Pediatric Residency: State University of New York Health Sciences Center at Brooklyn
Fellowship: University of Pittsburgh School of Medicine and University of Chicago Hospital and Biological Sciences Division Interests: Dr. Speers’ Laboratory, an NIH-funded laboratory in the Division of Neonatology of Stony Brook Children’s Hospital, focuses on the mechanisms of the neonatal sepsis-induced inflammatory response and central nervous system inflammation. Utilizing in vitro blood and tissue culture models and in vivo murine models of neonatal sepsis, Dr. Speers’ Lab aims to develop anti-inflammatory pharmacological therapies designed for use in neonates that can improve survival and developmental outcome and mitigate organ injury of infected term and preterm newborns. |